`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE EASTERN DISTRICT OF TEXAS
`TYLER DIVISION
`
`
`
`
`CIVIL ACTION NO.
`6:15-cv-00201-JRG-KNM
`
`JURY TRIAL DEMANDED
`
`''
`
`
`'
`'
`'
`'
`'
`'
`'
`'
`
`PLAINTIFF’S FIRST AMENDED COMPLAINT
`
`
`
`
`
`
`Pursuant to Fed. Civ. P. 15(a)(1)(b), Plaintiff FLEXUSPINE, INC. files this First
`
`Amended Complaint against Defendant GLOBUS MEDICAL, INC., alleging as follows:
`
`
`
`I. THE PARTIES
`
`1.
`
`FLEXUSPINE, INC. (“Plaintiff” or “Flexuspine”) is a corporation organized and
`
`existing under the laws of the State of Delaware, with a principal place of business in Tyler,
`
`Texas.
`
`2.
`
`Flexuspine is a company that develops novel devices for the treatment of
`
`degenerative spine disease.
`
`3.
`
`Upon information and belief, GLOBUS MEDICAL, INC. (“Globus”) is a
`
`corporation organized and existing under the laws of the State of Delaware, with its principal
`
`place of business located at 2560 General Armistead Avenue, Audubon, Pennsylvania. Globus
`
`has been served with process, made an appearance through counsel, and is presently before this
`
` 1
`
`
`
`Court.
`
`
`
`
`
`
`
`FLEXUSPINE, INC.
`
`
`
`Plaintiff,
`
`
`Defendant.
`
`v.
`
`GLOBUS MEDICAL, INC.,
`
`
`
`
`Case 6:15-cv-00201-JRG-KNM Document 17 Filed 06/26/15 Page 2 of 8 PageID #: 290
`
`4.
`
`Globus is a medical device company focused on the design, development and
`
`commercialization of musculoskeletal implants that promote healing in patients with spine
`
`disorders, including invertebral spinal fusion and minimally invasive spine products.
`
`II. JURISDICTION AND VENUE
`
`5.
`
`This is an action for patent infringement arising under the patent laws of the
`
`United States, Title 35 United States Code. This Court has exclusive subject matter jurisdiction
`
`over this case for patent infringement under 28 U.S.C. §1338(a). Venue is proper under 28
`
`U.S.C. §§ 1391(b) and (c).
`
`6.
`
`Upon information and belief, Globus has had minimum contacts with the Tyler
`
`Division of the Eastern District of Texas such that this venue is a fair and reasonable one. Globus
`
`has committed such purposeful acts and/or transactions in Texas that it reasonably knew and/or
`
`expected that it could be hailed into a court as a future consequence of such activity. Upon
`
`information and belief Globus has transacted and, at the time of the filing of this Complaint, is
`
`transacting business within the Tyler Division of the Eastern District of Texas.
`
`7.
`
`Flexuspine is an existing business located within the Tyler Division of the Eastern
`
`District of Texas. All of Flexuspine’s documents and prototypes relating to the Patents-in-Suit
`
`and its business are located in this Division.
`
`8.
`
`Two of the named inventors for the Patents-in-Suit and the founders of
`
`Flexuspine, Dr. Charles Gordon, M.D. and Corey Harbold, are located within the Tyler Division
`
`of the Eastern District of Texas.
`
`
`
`III. PATENTS-IN-SUIT
`
`9.
`
`On April 17, 2007, United States Patent No. 7,204,853 (“the ‘853 patent”) was
`
`duly and legally issued for an “ARTIFICIAL FUNCTIONAL SPINAL UNIT ASSEMBLIES.”
`
` 2
`
`
`
`
`
`
`
`Case 6:15-cv-00201-JRG-KNM Document 17 Filed 06/26/15 Page 3 of 8 PageID #: 291
`
`A true and correct copy of the ‘853 patent is attached hereto as Exhibit “A” and made a part
`
`hereof.
`
`10.
`
`On January 8, 2008, United States Patent No. 7,316,714 (“the ‘714 patent”) was
`
`duly and legally issued for an “ARTIFICIAL FUNCTIONAL SPINAL UNIT ASSEMBLIES.”
`
`A true and correct copy of the ‘714 patent is attached hereto as Exhibit “B” and made a part
`
`hereof.
`
`11.
`
`On March 22, 2011, United States Patent No. 7,909,869 (“the ‘869 patent”) was
`
`duly and legally issued for an “ARTIFICIAL SPINAL UNIT ASSEMBLIES.” A true and correct
`
`copy of the ‘869 patent is attached hereto as Exhibit “C” and made a part hereof.
`
`12.
`
`On February 28, 2012, United States Patent No. 8,123,810 (“the ‘810 patent”)
`
`was duly and legally issued for an “EXPANDABLE INTERVERTEBRAL IMPLANT WITH
`
`WEDGED EXPANSION MEMBER.” A true and correct copy of the ‘810 patent is attached
`
`hereto as Exhibit “D” and made a part hereof.
`
`13.
`
`On February 11, 2014, United States Patent No. 8,647,386 (“the ‘386 patent”)
`
`was duly and legally issued for an “EXPANDABLE INTERVERTEBRAL IMPLANT SYSTEM
`
`AND METHOD.” A true and correct copy of the ‘386 patent is attached hereto as Exhibit “E”
`
`and made a part hereof.
`
`14.
`
`Collectively, the ‘853, ‘714, ‘869, ‘810, and ‘386 patents are referred to as “the
`
`Patents-in-Suit.”
`
`15.
`
`As it pertains to this lawsuit, the Patents-in-Suit, very generally speaking, relate to
`
`a device which can be implanted between two vertebral bodies of a human spine to increase or
`
`maintain the separation distance between vertebrae (distraction) and facilitate the fusion of such
`
`vertebral bodies as treatment for degenerative spinal conditions.
`
` 3
`
`
`
`
`
`
`
`Case 6:15-cv-00201-JRG-KNM Document 17 Filed 06/26/15 Page 4 of 8 PageID #: 292
`
`16.
`
`In 2003, Dr. Gordon and Mr. Harbold, founded FSU Technologies, Inc. (later
`
`renamed Flexuspine) to design and develop devices for spinal surgery, including the devices
`
`disclosed in the Patents-in-Suit. With years of experience in spinal surgery and engineering,
`
`respectively, Dr. Gordon and Mr. Harbold conceived, reduced to practice, and patented an
`
`improved interbody fusion device that could be inserted between two vertebral bodies and then
`
`be expanded to provide distraction of the vertebral bodies, thereby decompressing the spine and
`
`facilitating spinal fusion as disclosed in the Patents-in-Suit.
`
`IV. FIRST CLAIM FOR RELIEF
`
`(Patent Infringement)
`
`17.
`
`Flexuspine is the owner of all right, title and interest of the Patents-in-Suit,
`
`including all rights to enforce and prosecute actions for infringement and to collect damages for
`
`all relevant times against infringers of the Patents-in-Suit. Accordingly, Flexuspine possesses the
`
`exclusive right and standing to prosecute the present action for infringement of the Patents-in-
`
`Suit by Globus.
`
`18.
`
`Upon information and belief, Globus manufactures, makes, has made, uses,
`
`practices, imports, provides, supplies, distributes, sells and/or offers for sale products and/or
`
`systems that infringe one or more claims of the Patents-in-Suit.
`
`19.
`
`Globus’ expandable intervertebral fusion devices including, at a minimum, the
`
`Caliber and Caliber-L have infringed in the past and continue to infringe at least one claim of the
`
`‘853 patent, at least one claim of the ‘869 patent, at least one claim of the ‘810 patent, and at
`
`least one claim of the ‘386 patent.
`
` 4
`
`
`
`
`
`
`
`Case 6:15-cv-00201-JRG-KNM Document 17 Filed 06/26/15 Page 5 of 8 PageID #: 293
`
`20.
`
`Globus’ expandable intervertebral fusion devices including, at a minimum, the
`
`Rise and Rise IntraLIF have infringed in the past and continue to infringe at least one claim of
`
`the ‘853 patent.
`
`21.
`
`Globus’s expandable intervertebral fusion devices including, at a minimum, the
`
`Altera have infringed in the past and continue to infringe at least one claim of the ‘714 patent and
`
`at least one claim of the ‘386 patent.
`
`22.
`
`As a result of Globus’s infringing conduct, Globus has damaged Flexuspine.
`
`Globus is, thus, liable to Flexuspine in an amount that adequately compensates Flexuspine for
`
`its’ infringement, which by law in no event can be less than a reasonable royalty, together with
`
`interest and costs as fixed by this Court under 35 U.S.C. § 284.
`
`23.
`
`As a consequence of Globus’s infringement, Flexuspine has been irreparably
`
`damaged and such damage will continue without the issuance of an injunction by this Court.
`
`24.
`
`Upon information and belief, Globus was on notice of the Patents-in-Suit and of
`
`its infringing conduct, and has, respectively, knowingly and willfully infringed the Patents-in-
`
`Suit at least as early as June 2014.
`
`25.
`
`Globus has had contact and communications with representatives acting on behalf
`
`of Flexuspine and has been fully aware of Flexuspine’s technology and patent portfolio,
`
`including Flexuspine’s allegations that Globus infringes the Patents-in-Suit, beginning in June
`
`2014.
`
`26.
`
`On or around June 4, 2014, representatives acting on behalf of Flexuspine notified
`
`Globus of its portfolio and its applicability to Globus’s products. In particular, on June 4, 2014,
`
`representatives of Flexuspine sent a presentation to Globus explaining how the patents in the
`
`Flexuspine portfolio cover a variety of Globus’s expandable intervertebral fusion devices,
`
` 5
`
`
`
`
`
`
`
`Case 6:15-cv-00201-JRG-KNM Document 17 Filed 06/26/15 Page 6 of 8 PageID #: 294
`
`including claim charts demonstrating the infringement of the Caliber and Caliber-L. Globus and
`
`representatives acting on behalf of Flexuspine had continuing communications about the
`
`Flexuspine patent portfolio and a potential license until July 9, 2014, at which point
`
`communications ceased.
`
`27.
`
`Since that time, Globus has proceeded to infringe the Patents-in-Suit with full and
`
`complete knowledge of the patents and objectively high likelihood that selling its products
`
`constituted infringement. Globus’s infringement of the Patents-in-Suit is willful and deliberate,
`
`entitling Flexuspine to increased damages under 35 U.S.C. § 284 and to attorneys’ fees and costs
`
`incurred in prosecuting this action under 35 U.S.C. § 285.
`
`
`
`V. JURY DEMAND
`
`Flexuspine hereby requests a trial by jury pursuant to Rule 38 of the Federal Rules of
`
`Civil Procedure.
`
`VI. PRAYER FOR RELIEF
`
`
`
`WHEREFORE, Flexuspine respectfully requests that the Court find in its favor and
`
`against Globus, and that the Court grant Flexuspine the following relief:
`
`a.
`
`b.
`
`c.
`
`d.
`
`Judgment that one or more claims of the Patents-in-Suit have been infringed,
`either literally and/or under the doctrine of equivalents, by Globus;
`
`Judgment that Globus’s infringement is willful from the time Globus became
`aware of the infringing nature of its products and that the Court award treble
`damages for the period of such willful infringement pursuant to 35 U.S.C. § 284.
`
`Judgment that Globus account for and pay to Flexuspine all damages to and costs
`incurred by Flexuspine because of Globus’s infringing activities and other
`conduct complained of herein;
`
`That Flexuspine be granted pre-judgment and post-judgment interest on the
`damages caused by Globus’s infringing activities and other conduct complained
`of herein;
`
`
` 6
`
`
`
`
`
`
`
`Case 6:15-cv-00201-JRG-KNM Document 17 Filed 06/26/15 Page 7 of 8 PageID #: 295
`
`e.
`
`f.
`
`g.
`
`That the Court declare this an exceptional case and award Flexuspine its
`reasonable attorney’s fees and costs in accordance with 35 U.S.C. § 285;
`
`That Globus be permanently enjoined from any further activity or conduct that
`infringes one or more claims of the Patents-in-Suit; and
`
`That Flexuspine be granted such other and further relief as the Court may deem
`just and proper under the circumstances.
`
`
`Dated: June 26, 2015.
`
`
`
`
`
`Respectfully submitted,
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/s/ Mark D. Strachan
`
` Mark D. Strachan
`
`Texas State Bar No. 19351500
`
`SAYLES│WERBNER, P.C.
`
`1201 Elm Street, Suite 4400
` Dallas, Texas 75270
`
`(214) 939-8700 – Telephone
`(214) 939-8787 – Facsimile
`mstrachan@swtriallaw.com
`
`Jonathan T. Suder
`State Bar No. 19463350
`Brett M. Pinkus
`State Bar No. 24076625
`Todd I. Blumenfeld
`State Bar No. 24067518
`FRIEDMAN, SUDER & COOKE
`Tindall Square Warehouse No. 1
`604 East 4th Street, Suite 200
`Fort Worth, Texas 76102
`(817) 334-0400 - Telephone
`(817) 334-0401 - Facsimile
`jts@fsclaw.com
`pinkus@fsclaw.com
`blumenfeld@fsclaw.com
`
` ATTORNEYS FOR PLAINTIFF
`FLEXUSPINE, INC.
`
`
`CERTIFICATE OF SERVICE
`
`
` 7
`
`
`
`
`
`
`
`Case 6:15-cv-00201-JRG-KNM Document 17 Filed 06/26/15 Page 8 of 8 PageID #: 296
`
`The undersigned hereby certifies that, on this the 26th day of June, 2015, the foregoing document
`was filed electronically in compliance with Local Rule CV-5(a). As such, this document was
`served on all counsel who have consented to electronic service. Local Rule CV-5(a)(3)(A).
`
`
`/s/_Mark D. Strachan___________
`Mark D. Strachan
`
`
`
`
`
`
`
` 8
`
`
`
`
`
`
`
`